The Aroon Indicator for BKD entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 162 similar instances where the Aroon Indicator formed such a pattern. In 140 of the 162 cases the stock moved lower. This puts the odds of a downward move at 86%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BKD as a result. In 62 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for BKD turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 38 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
BKD moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BKD's RSI Indicator exited the oversold zone, 24 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where BKD advanced for three days, in 228 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
BKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-74.262) is normal, around the industry mean (204.532). P/E Ratio (-15.271) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (2.498). Dividend Yield (0.111) settles around the average of (0.154) among similar stocks. P/S Ratio (0.916) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. BKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Be on the lookout for a price bounce soon.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CMPS's RSI Indicator exited the oversold zone, 30 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CMPS advanced for three days, in 222 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CMPS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CMPS as a result. In 74 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for CMPS turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 39 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMPS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for CMPS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.104) is normal, around the industry mean (204.532). P/E Ratio (-2.272) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. CMPS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMPS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
BKD | CMPS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 61 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 43 Fair valued | |
PROFIT vs RISK RATING 1..100 | 83 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 75 | 64 | |
P/E GROWTH RATING 1..100 | 13 | 18 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BKD's Valuation (6) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CMPS (43) in the null industry. This means that BKD’s stock grew somewhat faster than CMPS’s over the last 12 months.
BKD's Profit vs Risk Rating (83) in the Hospital Or Nursing Management industry is in the same range as CMPS (100) in the null industry. This means that BKD’s stock grew similarly to CMPS’s over the last 12 months.
BKD's SMR Rating (100) in the Hospital Or Nursing Management industry is in the same range as CMPS (100) in the null industry. This means that BKD’s stock grew similarly to CMPS’s over the last 12 months.
CMPS's Price Growth Rating (64) in the null industry is in the same range as BKD (75) in the Hospital Or Nursing Management industry. This means that CMPS’s stock grew similarly to BKD’s over the last 12 months.
BKD's P/E Growth Rating (13) in the Hospital Or Nursing Management industry is in the same range as CMPS (18) in the null industry. This means that BKD’s stock grew similarly to CMPS’s over the last 12 months.
| BKD | CMPS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 72% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 89% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| Advances ODDS (%) | 9 days ago 78% | 8 days ago 84% |
| Declines ODDS (%) | 1 day ago 76% | 2 days ago 87% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 79% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BKD’s FA Score shows that 2 FA rating(s) are green while CMPS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BKD’s TA Score shows that 4 TA indicator(s) are bullish while CMPS’s TA Score has 4 bullish TA indicator(s).
BKD (@Hospital/Nursing Management) experienced а -6.18% price change this week, while CMPS (@Hospital/Nursing Management) price change was -12.69% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -10.44%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +3.25%.
BKD is expected to report earnings on Feb 23, 2027.
CMPS is expected to report earnings on Mar 04, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, BKD has been loosely correlated with SNDA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BKD jumps, then SNDA could also see price increases.
| Ticker / NAME | Correlation To BKD | 1D Price Change % | ||
|---|---|---|---|---|
| BKD | 100% | -2.39% | ||
| SNDA - BKD | 47% Loosely correlated | -0.46% | ||
| ENSG - BKD | 36% Loosely correlated | -1.63% | ||
| MD - BKD | 29% Poorly correlated | -0.93% | ||
| THC - BKD | 29% Poorly correlated | -3.80% | ||
| HCA - BKD | 26% Poorly correlated | -4.96% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CMSA | 18.38 | 0.19 | +1.04% |
| CMS Energy Corp | |||
| CGGG | 25.82 | 0.03 | +0.14% |
| Capital Group U.S. Large Growth ETF | |||
| DINT | 26.38 | -0.43 | -1.60% |
| Davis Select International ETF (DINT) | |||
| RNEM | 55.45 | -1.19 | -2.10% |
| First Trust Emerging Markets Equity Select ETF (RNEM) | |||
| BCX | 10.70 | -0.51 | -4.55% |
| Blackrock Resources & Commodities Strategy Trust | |||